News Releases
Dr. Cynthia Bamdad, CEO of Minerva Biotechnologies, will present a talk at the International Society for Cellular Therapy conference in Montreal. The talk is entitled:
Novel CAR T that Targets MUC1* Not Full-Length MUC1 for Treatment of Solid Tumor Cancers